BACKGROUND: A genome-wide association study (GWAS) identified significant association between variants in MEIS1, BTBD9, and MAP2K5/SKOR1 and restless legs syndrome (RLS). However, many independent replication studies are needed to unequivocally establish a valid genotype-phenotype association across various populations. To further validate the GWAS findings, we investigated three variants, rs2300478 in MEIS1, rs9357271 in BTBD9, and rs1026732 in MAP2K5/SKOR1 in 38 RLS families and 189 RLS patients/560 controls from the US for their association with RLS. METHOD: Both family-based and population-based case-control association studies were carried out. RESULTS: The family-based study showed that SNP rs1026732 in MAP2K5/SKOR1 was significantly associated with RLS (P=0.01). Case-control association studies showed significant association between all three variants and RLS (P=0.0001/OR=1.65, P=0.0021/OR=1.59, and P=0.0011/OR=1.55 for rs2300478, rs9357271, and rs1026732, respectively). CONCLUSION: Variants in MEIS1, BTBD9, and MAP2K5/SKOR1 confer a significant risk of RLS in a US population.
BACKGROUND: A genome-wide association study (GWAS) identified significant association between variants in MEIS1, BTBD9, and MAP2K5/SKOR1 and restless legs syndrome (RLS). However, many independent replication studies are needed to unequivocally establish a valid genotype-phenotype association across various populations. To further validate the GWAS findings, we investigated three variants, rs2300478 in MEIS1, rs9357271 in BTBD9, and rs1026732 in MAP2K5/SKOR1 in 38 RLS families and 189 RLSpatients/560 controls from the US for their association with RLS. METHOD: Both family-based and population-based case-control association studies were carried out. RESULTS: The family-based study showed that SNP rs1026732 in MAP2K5/SKOR1 was significantly associated with RLS (P=0.01). Case-control association studies showed significant association between all three variants and RLS (P=0.0001/OR=1.65, P=0.0021/OR=1.59, and P=0.0011/OR=1.55 for rs2300478, rs9357271, and rs1026732, respectively). CONCLUSION: Variants in MEIS1, BTBD9, and MAP2K5/SKOR1 confer a significant risk of RLS in a US population.
Authors: Byron C Jones; Cheryl L Reed; Robert Hitzemann; Jason A Wiesinger; Kristin A McCarthy; James P Buwen; John L Beard Journal: Nutr Neurosci Date: 2003-12 Impact factor: 4.994
Authors: Richard P Allen; Daniel Picchietti; Wayne A Hening; Claudia Trenkwalder; Arthur S Walters; Jacques Montplaisi Journal: Sleep Med Date: 2003-03 Impact factor: 3.492
Authors: Maria Teresa Bonati; Luigi Ferini-Strambi; Paolo Aridon; Alessandro Oldani; Marco Zucconi; Giorgio Casari Journal: Brain Date: 2003-06 Impact factor: 13.501
Authors: Amanda Freeman; Elaine Pranski; R Daniel Miller; Sara Radmard; Doug Bernhard; H A Jinnah; Ranjita Betarbet; David B Rye; Subhabrata Sanyal Journal: Curr Biol Date: 2012-05-31 Impact factor: 10.834
Authors: Myeong-Kyu Kim; Yong Won Cho; Won Chul Shin; Jae Wook Cho; Young Min Shon; Jee Hyun Kim; Kwang Ik Yang; Christopher J Earley; Richard P Allen Journal: Sleep Date: 2013-12-01 Impact factor: 5.849
Authors: Angela Roco; Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Carmen Martínez; Martín Zurdo; Laura Turpín-Fenoll; Jorge Millán; Teresa Adeva-Bartolomé; Esther Cubo; Francisco Navacerrada; Ana Rojo-Sebastián; Lluisa Rubio; Marisol Calleja; José Francisco Plaza-Nieto; Belén Pilo-de-la-Fuente; Margarita Arroyo-Solera; Elena García-Martín; José A G Agúndez Journal: J Neural Transm (Vienna) Date: 2012-09-22 Impact factor: 3.575